Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation

Eur Heart J. 2006 Sep;27(17):2034-5. doi: 10.1093/eurheartj/ehl019. Epub 2006 Aug 7.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Atrial Function / physiology
  • Biphenyl Compounds / therapeutic use*
  • Electric Countershock*
  • Humans
  • Irbesartan
  • Tetrazoles / therapeutic use*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Biphenyl Compounds
  • Tetrazoles
  • Irbesartan